SMTL ID : 9ars.1

Crystal structure of SARS-CoV-2 main protease E166V mutant in complex with an inhibitor TKB-245

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

homo-dimer

Ligands

2 x T2L: (1R,2S,5S)-N-{(1S,2S)-1-(4-fluoro-1,3-benzothiazol-2-yl)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide(Covalent)

T2L.1: 22 residues within 4Å: Chain A: T.25, H.41, C.44, M.49, Y.54, F.140, N.142, G.143, S.144, C.145, H.163, H.164, M.165, V.166, L.167, P.168, H.172, D.187, R.188, Q.189, T.190, Q.192 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:T.25, A:H.41, A:M.165, A:V.166 Hydrogen bonds: A:F.140, A:G.143, A:S.144, A:S.144, A:C.145, A:H.164, A:V.166, A:V.166, A:T.190 T2L.2: 23 residues within 4Å: Chain A: S.1 Chain B: T.25, H.41, C.44, M.49, F.140, L.141, N.142, G.143, S.144, C.145, H.163, H.164, M.165, V.166, L.167, P.168, H.172, D.187, R.188, Q.189, T.190, Q.192 12 PLIP interactions: 2 interactions with chain A, 10 interactions with chain B Hydrogen bonds: A:S.1, A:S.1, B:G.143, B:S.144, B:C.145, B:H.164, B:V.166, B:V.166, B:T.190 Hydrophobic interactions: B:T.25, B:M.165, B:V.166

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hattori, S. et al., Structural and virologic mechanism of emergence of main protease inhibitor-resistance in SARS-CoV-2 as selected with main protease inhibitors. To Be Published

Release Date

2024-04-24

Peptides

3C-like proteinase nsp5: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

3C-like proteinase nsp5

Related Entries With Identical Sequence